BRAINSGATE
BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developed the ISS, based on a miniature electrode implanted at the roof of the mouth in a bed side, minimally invasive, local anesthesia procedure comparable to denta... l treatment. In 2008, the company completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. In 2011 the Company completed a 300 patients RCT pivotal trial that further substantiated the safety and efficacy of its treatment for acute ischemic stroke patients. BrainsGate is currently running the ImpACT-24b, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24-hour window.
BRAINSGATE
Social Links:
Industry:
Consulting Health Care Internet Medical Device Therapeutics
Founded:
2002-01-01
Address:
Caesarea, Hefa, Israel
Country:
Israel
Website Url:
http://www.brainsgate.com
Total Employee:
11+
Status:
Active
Contact:
+97246377774
Total Funding:
98.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Domain Not Resolving Mobile Non Scaleable Content Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Contents Lab. Blue
Webtoon production company that aims to provide different contents to various markets around the world.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
JobTeaser
JobTeaser is a European job board platform for students and recent grads.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
SceneRay
SceneRay is a medical device company dedicated to the design, Development, and distribution of neuromodulation devices.
Current Advisors List
Current Employees Featured
Founder
Investors List
Agate Medical Investments
Agate Medical Investments investment in Series F - Brainsgate
Cipio Partners
Cipio Partners investment in Series F - Brainsgate
Elron Ventures
Elron Ventures investment in Series F - Brainsgate
Pitango Venture Capital
Pitango Venture Capital investment in Series F - Brainsgate
Medtronic
Medtronic investment in Series F - Brainsgate
Spero Ventures
Spero Ventures investment in Series F - Brainsgate
BNP Paribas
BNP Paribas investment in Series F - Brainsgate
Elron Ventures
Elron Ventures investment in Venture Round - Brainsgate
Elron Ventures
Elron Ventures investment in Series C - Brainsgate
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Brainsgate
Official Site Inspections
http://www.brainsgate.com
- Host name: mail.stick.tyco.co.il
- IP address: 195.28.180.198
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "Brainsgate"
Brainsgate - Crunchbase Company Profile & Funding
BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developed the ISS, based on a miniature electrode implanted at …See details»
Brainsgate - LinkedIn
Brainsgate | 2,336 followers on LinkedIn. BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases. The ...See details»
BrainsGate Company Profile 2024: Valuation, Funding …
BrainsGate General Information Description. Developer of a medical device intended to design therapies for patients suffering from central nervous system diseases. The company's technology involves electrical stimulation of the …See details»
BrainGate - Turning Thought Into Action
BrainGate: a leading team of physicians, scientists and engineers. An extraordinary collaboration of internationally recognized laboratories, universities, and hospitals, streamlining the research …See details»
BrainGate - Wikipedia
BrainGate is a brain implant system, currently under development and in clinical trials, designed to help those who have lost control of their limbs, or other bodily functions, such as patients with amyotrophic lateral sclerosis (ALS) or spinal cord injury. The Braingate technology and related Cyberkinetic’s assets are now owned by privately held Braingate, Co. The sensor, which is implanted into the brain, monitors brain activity in the patient and converts the intention of the us…See details»
Facial nerve stimulation as a future treatment for ischemic stroke
Dec 6, 2016 One explanation is that the IMPACT-24Bt clinical trial reflects BrainsGate's confidence in their device as a treatment for a broad range of ischemic stroke patients as …See details»
BrainsGate Ltd. Asset Profile | Preqin
Founded in 2000 and based in Caesarea, Israel, BrainsGate Ltd. is a medical device company that focuses on the development of therapies for patients suffering from central nervous …See details»
BrainGate Company Profile 2024: Valuation, Funding & Investors
BrainGate General Information Description. Developer of neural interface systems designed to communicate and use robotics assistive devices. The company focuses on developing …See details»
BrainsGate | Insights
Oct 25, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
BrainsGate Ltd. - insights.citeline.com
BrainsGate Ltd. 01 Jul 2006 On the way to developing a neurostimulation device for delivering drugs across the blood grain barrier, BrainsGate has hit upon a novel acute stroke treatment …See details»
BrainsGate raises $14M - MassDevice
Dec 7, 2020 BrainsGate’s technology already has CE Mark approval and the company filed for PMA with the FDA for U.S. clearance in February 2020. Subject to the PMA, the company …See details»
December 10, 2021: Neurological Devices Panel of the Medical …
On December 10, 2021, the committee will discuss, make recommendations, and vote on information regarding the premarket approval application (PMA) for the BrainsGate Ischemic …See details»
Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT …
Jul 3, 2019 The study was funded by BrainsGate Ltd, Caesarea, Israel (www.brainsgate.com). N.B. and H.C.D. received contracted hourly payments from BrainsGate for service on the …See details»
Implant for Augmentation of Cerebral Blood Flow Trial-1
Jul 3, 2019 The results call for a follow-up randomized trial (funded by BrainsGate; clinicaltrials.gov number, NCT03733236). Implant for Augmentation of Cerebral Blood Flow …See details»
Brief Summary of the Neurological Devices Panel Meeting …
The BrainsGate Ischemic Stroke System (ISS500) by BrainsGate Ltd. The sponsor has proposed the following Indications for Use: The ISS500 is indicated to increase cerebral blood flow and …See details»
ImpACT-24B(Implant Augmenting Cerebral blood flow) Rev 1.0
ImpACT-24B- Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window. BrainsGate is conducting its worldwide Investigational Device Pivotal …See details»
Researchers discuss BrainGate, restorative neurotechnology at …
Oct 14, 2020 PROVIDENCE, R.I. [Brown University] — In 2012, a research team led by neuroengineers from Brown University published a landmark study in the field of restorative …See details»
BrainsGate - Raised $97M Funding from 13 investors - Tracxn
BrainsGate has raised a total funding of $97M over 5 rounds from 13 investors. Investors include Johnson & Johnson Innovation – JJDC, BNP Paribas and 11 others. Their latest funding round …See details»
Technologies and Startups that Hack the Brain
Mar 1, 2019 BrainsGate’s technology is based on electrical stimulation of the sphenopalatine ganglion that increases cerebral blood flow. In a case of an acute ischemic stroke blood …See details»
Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT …
BrainsGate. The study was designed by an Academic Steering Committee and the sponsor, BrainsGate Ltd. Site management and data collection were coordinated by the sponsor. Data …See details»